You have seen the headlines. A weight-loss shot that also turns back the clock. Before-and-after photos, people who look years younger, and a quiet hope underneath: maybe the drug everyone is talking about could add years to your life, not just take pounds off your body.
Do GLP-1 drugs like Ozempic actually slow aging?
Not yet, at least not in any proven way. GLP-1 drugs, the family that includes Ozempic, Wegovy, and Mounjaro, work by copying a gut hormone that tells your brain you are full and helps steady your blood sugar. They are approved to treat type 2 diabetes, to manage weight, and to lower heart risk. No drug on Earth is approved to treat aging itself, because health regulators do not count aging as a disease. A headline saying otherwise is describing early research, not a settled fact.
In 2026, researchers led by the University of California San Diego reported that semaglutide, the medicine inside Ozempic and Wegovy, slowed several DNA aging clocks in a small trial. The scientists chose their words with care. They were not saying the drug reverses aging or makes anyone younger. They called it a signal, and in science a signal is like smoke on the horizon: a real reason to go look, not proof that there is a fire.
So what is a DNA aging clock? If your birthday is the year on the chassis, this is meant to be the mileage. A lab reads tiny chemical tags on your DNA, which scientists call epigenetic marks, and uses them to estimate how worn your cells actually are. Two people the same age can read very differently, which is why your biological age can differ from your real age.
What did the actual study find?
The study was small, and the group was unusual. It followed 84 adults, 45 on semaglutide and 39 on a placebo (a dummy shot with no medicine, used for comparison), all living with HIV and a specific kind of body-fat change linked to their treatment. Over 32 weeks, one of their aging clocks (a well-known test called DunedinPACE, which measures how fast a person is aging) slowed by about 9 percent. Their cells looked a little younger than before.
The catch the headlines skip: this aging result was not the trial's main goal. It was an extra look at the data afterward, and when you go digging through numbers after the fact you can almost always find a pattern that turns out to be a fluke, like shapes in passing clouds. The authors also say the most likely reason is simple. The drug helped these people lose belly fat. It is a promising starting point, not proof that Ozempic is an anti-aging drug. It also studied one narrow group, so the result may not carry over to a healthy person at all.
Is the anti-aging effect really separate from weight loss?
The exciting claim is that these drugs slow aging through some special channel of their own, on top of the weight loss. In humans, that has not been shown.
Those DNA aging clocks are tightly linked to body fat and to inflammation, the low, constant irritation that extra fat keeps switched on inside the body. So losing a lot of fat moves the clock all by itself. A randomised weight-loss trial called MACRO, published in *Aging Cell* in 2025, showed exactly this. When people lost weight, their health improvements did not track with their aging-clock changes. The clock was following the fat, not some separate aging switch.
There is one result that hints at a real, weight-independent effect. In 2025, a team at the Chinese University of Hong Kong reversed aging markers in old mice without changing their weight. That sounds like the missing proof, until you read the fine print. It used exenatide, an older cousin of these drugs, not the semaglutide in Ozempic. It was done in mice, not people. And it never measured lifespan. Interesting for scientists. Not yet a reason for anyone to take anything.
What are the trade-offs nobody puts in the headline?
Real ones, and they land hardest on older adults, the exact group most interested in living longer.
You lose muscle, not just fat. Between a quarter and 40 percent of the weight lost is lean muscle: about a quarter when 22 trials are pooled, nearer 40 in the body-scan sub-studies of the big semaglutide trials. Losing muscle as you age is the opposite of what keeps you steady on your feet.
Bones may pay a price. Among more than 46,000 adults over 65, GLP-1 users had about an 11 percent higher rate of broken bones. It showed up in the 65-to-75s and not in the over-75s, and the study watched people rather than testing them, so nobody has shown the drug caused it.
There is a rare but serious risk. Britain's medicines regulator has logged 1,296 reports of acute pancreatitis, a painful and sometimes dangerous swelling of the pancreas, in people taking these drugs up to October 2025, 19 of them fatal. Reports are not a rate: they tell you the signal is real, not how often it happens.
The weight comes back. When people stop, roughly two thirds of the lost weight returns within about a year. And if any aging benefit depends on the weight loss, it may fade once you stop.
Why are we suddenly hearing "anti-aging" now?
Follow the money. Some of the loudest biological-age numbers come not from the UCSD trial above but from a separate analysis run by the drug's own maker, shown at a conference and not yet fully peer reviewed, meaning independent experts have not yet checked it line by line. Around the same time, the company's weight-loss sales cooled and its leaders began talking publicly about longevity.
None of that makes the science wrong. Early research is still research. But when the loudest cheering comes from the party with the most to gain, it is a good moment to ask for stronger proof, not less.
So what actually slows aging that you can do today?
The things that reliably move those same aging clocks are mostly things you already control, and they cost nothing.
Protect your muscle. Lifting, resistance bands, or bodyweight work two or three times a week, plus enough protein, keeps the strength that aging, and these drugs, tend to strip away.
Lose fat the durable way. Since fat loss and lower inflammation are what actually move the clocks, the everyday basics win. A steady eating window helps mainly by making most people eat less, which is the part that moves the numbers.
Sleep like it counts. Your body does most of its repair work while you sleep. Our Vitality Calculator scores the habits on this list in two minutes. It reads your routine, not your cells.
The takeaway is not that GLP-1 drugs are bad. For the right person, under a doctor's care, they can be genuinely important for diabetes and weight. They are not a proven fountain of youth, the aging claims are early and mostly explained by weight loss, and the strongest tools for a longer, stronger life are still the ones in your own hands. If a drug ever earns the anti-aging title, it will do it with a real trial, not a headline.
What to do tomorrow
Nothing that needs a prescription.
Tomorrow, after you have eaten rather than first thing, put a kitchen chair against a wall. Fold your arms across your chest and stand up five times, timing yourself. Stop if you feel dizzy or unsteady. And if you cannot do it at all without pushing off with your hands, that is your reading. It belongs in front of a doctor, not in another attempt.
Write the seconds and the date in your phone, then set a reminder for a month.
There is no score to beat here. The only number worth anything is your own, a month later, done the same way. If it climbs while you are on one of these drugs, that is the muscle question above turned into something you can actually watch, and it belongs in your next appointment. Never in a decision to stop a medicine that may be helping you.
